1544 results Niet (meer) klagen over bestuurders Jan-Maarten Schepel bespreekt de recente uitspraak van de Hoge Raad over de toepassing van de klachtplicht op bestuurdersaansprakelijkheid. Nederlands stakingsrecht op orde Deze zomer wees het Europees Sociaal Comité voor Sociale Rechten (ECSR) de klachten af die FNV en CNV hadden ingediend over het Nederlandse stakingsrecht. Court of Appeal overturns first instance judgment and establishes that several prestressing steel producers are liable for the potential loss alleged by Deutsche Bahn The Court of Appeal of 's-Hertogenbosch ruled that several producers of prestressing steel are jointly and severally liable for potential loss that Deutsche Bahn may have suffered as a result of an infringement of competition law rules. If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug. The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite. Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices. You win some, you lose some: Google AdSense decision annulled The General Court has annulled the EUR 1.49 billion fine imposed on Google. The Commission had failed to properly assess the allegedly abusive contractual clauses related to online advertising, including whether they actually had a lock-in effect. Energieprojecten op gronden van de overheid: overheidsopdracht, concessie of geen van beide? De Raad van State oordeelde in een arrest van 8 december 2022 of er sprake is van een overheidsopdracht, een concessie of geen van beide in situaties waarin een overheid gronden ter beschikking stelt voor de ontwikkeling van energieprojecten. Afschaffing constitutioneel toetsingsverbod in consultatie. Wat stelt de regering precies voor? De regering wil het verbod op constitutionele toetsing gedeeltelijk afschaffen. Rechters zouden formele wetten kunnen toetsen aan klassieke grondrechten. Wat betekent dit conceptwetsvoorstel voor de Nederlandse rechtsstaat? ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom. Het verschoningsrecht is niet zomaar prijsgegeven Het verschoningsrecht blijft de gemoederen bezighouden. Verschoningsgerechtigde informatie omvat alle informatie die aan een advocaat is toevertrouwd door zijn cliënt in het kader van hun professionele relatie. Reporting for non-EU AIFMs as of Q1 2023 Effective from Q1 2023, the Netherlands Authority for the Financial Markets (the “AFM”) indicated that it will require AIFMs who have notified AIFs for marketing under Article 36/Article 42 AIFMD to submit Periodic Reports. Meta fined for Facebook Marketplace’s Unfair Trading Conditions and Tying Unfair trading conditions and tying are gaining traction as alleged abusive practices in the digital industry, as the European Commission fines Meta EUR 797.72 million for hindering competitors of Facebook Marketplace. The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines. Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies. Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission. Schenden wetenschappelijke integriteit leidt tot rechtsgeldig intrekken doctorsgraad (annotatie) In deze annotatie bespreken Astrid Helstone en Lili Szuhai een uitspraak van de Afdeling bestuursrechtspraak van de Raad van State (de Afdeling) waarin de intrekking van de doctorsgraad van een gepromoveerde onderzoeker centraal stond. Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update! Pagination Previous page Page 75 Current page 76 Page 77 Page 78 Next page
Niet (meer) klagen over bestuurders Jan-Maarten Schepel bespreekt de recente uitspraak van de Hoge Raad over de toepassing van de klachtplicht op bestuurdersaansprakelijkheid.
Nederlands stakingsrecht op orde Deze zomer wees het Europees Sociaal Comité voor Sociale Rechten (ECSR) de klachten af die FNV en CNV hadden ingediend over het Nederlandse stakingsrecht.
Court of Appeal overturns first instance judgment and establishes that several prestressing steel producers are liable for the potential loss alleged by Deutsche Bahn The Court of Appeal of 's-Hertogenbosch ruled that several producers of prestressing steel are jointly and severally liable for potential loss that Deutsche Bahn may have suffered as a result of an infringement of competition law rules.
If you have nothing nice to say…Teva fined heavily for abusive conduct Dominant pharma companies had better watch their words and use the patent system wisely. Pharma company Teva was fined EUR 462.6 million for disparagement and ‘divisional gaming’ to delay market entry and hinder the uptake of a competing drug.
The Commission’s ‘killer’ pharma campaign: reason to complain? The European Commission is on the prowl in the pharma sector. Recent cases on alleged disparagement and pipeline drugs-killings show that it is not afraid to show its teeth and, ultimately, bite.
Qualcomm falls prey to EU court’s predatory pricing ruling The EU General Court confirms that Qualcomm’s below-cost pricing strategy designed to eliminate competition was predatory. This judgment, the first of its kind in over a decade, provides useful guidance on predatory pricing practices.
You win some, you lose some: Google AdSense decision annulled The General Court has annulled the EUR 1.49 billion fine imposed on Google. The Commission had failed to properly assess the allegedly abusive contractual clauses related to online advertising, including whether they actually had a lock-in effect.
Energieprojecten op gronden van de overheid: overheidsopdracht, concessie of geen van beide? De Raad van State oordeelde in een arrest van 8 december 2022 of er sprake is van een overheidsopdracht, een concessie of geen van beide in situaties waarin een overheid gronden ter beschikking stelt voor de ontwikkeling van energieprojecten.
Afschaffing constitutioneel toetsingsverbod in consultatie. Wat stelt de regering precies voor? De regering wil het verbod op constitutionele toetsing gedeeltelijk afschaffen. Rechters zouden formele wetten kunnen toetsen aan klassieke grondrechten. Wat betekent dit conceptwetsvoorstel voor de Nederlandse rechtsstaat?
ECJ in Towercast: plan C for tackling concentrations? Companies beware: completed non-notifiable concentrations do not necessarily go scot-free. An ex post abuse-of-dominance investigation by national competition authorities (NCA) could still loom.
Het verschoningsrecht is niet zomaar prijsgegeven Het verschoningsrecht blijft de gemoederen bezighouden. Verschoningsgerechtigde informatie omvat alle informatie die aan een advocaat is toevertrouwd door zijn cliënt in het kader van hun professionele relatie.
Reporting for non-EU AIFMs as of Q1 2023 Effective from Q1 2023, the Netherlands Authority for the Financial Markets (the “AFM”) indicated that it will require AIFMs who have notified AIFs for marketing under Article 36/Article 42 AIFMD to submit Periodic Reports.
Meta fined for Facebook Marketplace’s Unfair Trading Conditions and Tying Unfair trading conditions and tying are gaining traction as alleged abusive practices in the digital industry, as the European Commission fines Meta EUR 797.72 million for hindering competitors of Facebook Marketplace.
The ECJ’s ruling in Servier: Never Settle For Less Patent settlement agreements between originator pharmaceutical companies and generics manufacturers are a risky business. Originator medicine company Servier and five generic companies rolled the dice and the ECJ largely confirmed their antitrust fines.
Sharing is caring? Commission can take over NCA probe The EU case cooperation mechanism does not create any rights for companies to have their case dealt with by a particular competition authority. Companies should therefore factor the dynamics of this cooperation mechanism into their defence strategies.
Mayday, Mayday: Pay day! The Commission’s fight to avoid paying interest to Deutsche Telekom is over. The ECJ upheld the right of companies to receive interest on unduly collected antitrust fines, carrying a hefty price tag for the Commission.
Schenden wetenschappelijke integriteit leidt tot rechtsgeldig intrekken doctorsgraad (annotatie) In deze annotatie bespreken Astrid Helstone en Lili Szuhai een uitspraak van de Afdeling bestuursrechtspraak van de Raad van State (de Afdeling) waarin de intrekking van de doctorsgraad van een gepromoveerde onderzoeker centraal stond.
Get ready for more action! Dutch investment screening continues to evolve Dutch investment screening is rapidly expanding: since June, the proposal for a separate defence regime has been published and the intended expansion of the regime of the Vifo Act to include AI and biotech has been announced. Reason for a quick update!